What Researchers Did
Researchers conducted a mixed-method systematic review to identify the association between mucormycosis and COVID-19 in critically ill or immunocompromised patients.
What They Found
The review of 20 articles found that mucormycetes growth is linked to factors like hyperglycemia from diabetes or steroid use, increased ferritin levels, and immunosuppression. Reduced white blood cell count and activity in COVID-19 patients also contribute to fungal spore germination, increasing susceptibility to rhinocerebral mucormycosis, especially in hematological patients.
What This Means for Canadian Patients
Canadian patients with COVID-19, especially those with diabetes, on steroids, or who are immunocompromised, should be monitored for signs of rhinocerebral mucormycosis. Clinicians should be aware of these risk factors to ensure timely diagnosis and management, potentially improving patient outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this systematic review is its reliance on a single database (Google Scholar) and a high proportion of narrative reviews and case reports among the included articles.